A method for preventing drug-induced ototoxicity in an individual in need thereof comprising intratympanic administration of a pharmaceutical composition comprising a therapeutic agent, wherein the therapeutic agent is an antioxidant or anti-apoptotic agent, wherein the pharmaceutical composition is administered prior to onset of therapy with the drug, and wherein the composition provides sustained release of the therapeutic agent into the ear for a period of at least 5 days after a single administration
Additionally, it is important to consider the dosage and concentration of glutathione in the supplement
The gel transforms into a thin, translucent layer upon application, indicating full absorption of active ingredients
Cancer-related tissue damage BPC-157's angiogenic properties are a theoretical concern in the context of existing tumors
Damaged red neurons, without any inflammatory reaction, were present in all animals in more than 30% but less than 50% of hippocampal neurons, neurons of the dentate nucleus, Purkinje cells and other cerebellar nuclei